Enfermedad tromboembólica y anticonceptivos de tercera generación

Cobo, B.; Armengol, R.; Clemente, P.A.

doi:10.1016/S0304-5013(04)75957-9

Información del artículo

Resumen

Bibliografía

Descargar PDF

Estadísticas

Resumen

La tromboembolia pulmonar es un proceso infrecuente. Presentamos un caso de tromboembolia pulmonar en una paciente joven, que se asocia al tratamiento con contraceptivos orales de tercera generación. Aunque la tromboembolia pulmonar es un trastorno infrecuente, en vista de la gravedad del proceso sería importante tenerla en cuenta antes de iniciar este tipo de tratamiento en pacientes jóvenes.

Se lleva a cabo, asimismo, una revisión de los diferentes artículos publicados sobre riesgo tromboembólico y el uso de anticonceptivos de tercera generación.

Palabras clave:

Trombosis venosa

Riesgo tromboembólico

Anticonceptivos orales

Abstract

Pulmonary thromboembolic disease (PTD) is rare. We report the case of a young woman who presented PTD associated with third-generation oral contraceptives. Although PTD is infrequent, due to its seriousness, it should be taken into account before prescribing this kind of treatment to young patients.

We also provide a review of the literature on thromboembolic risk and third-generation oral contraceptives.

Key words:

Venous thrombosis

Thromboembolic risk

Oral contraceptives

El Texto completo está disponible en PDF

Bibliografía

[1.]

A.V. Sapp, Lindbloom E.J..

Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?.

J Fam Pract, 50 (2001), pp. 893

Medline

[2.]

J. Rosing, J. Curvers, G. Tans.

Oral contraceptives, thrombosis and haemostasis.

Eur J Obstet Gynecol Reprod Biol, 95 (2001), pp. 193-197

Medline

[3.]

F.R. Rosendaal, F.M. Helmerhorst, J.P. Vandenbroucke.

Oral contraceptives hormone replacement therapy and thrombosis.

Thromb Haemost, 86 (2001), pp. 112-123

Medline

[4.]

W.O. Spitzer, M.A. Lewis, L.A. Heinemann, M. Thorogood, K.D. MacRae.

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Bmj, 312 (1996), pp. 83-88

Medline

[5.]

G. Tans, J. Curvers, S. Middeldorp, M.C. Thomassen, J.C. Meijers, M.H. Prins, et al.

A randomized cross-over study on the effects of levonorgestrel-and desogestrel-containing oral contraceptives on the anticoagulant pathways.

Thromb Haemost, 84 (2000), pp. 15-21

Medline

[6.]

S. Middeldorp, J.C. Meijers, A.E. Van den Ende, A. Van Enk, B.N. Bouma, G. Tans, et al.

Effects on coagulation of levonorgestrel-and desogestrel-containing low dose oral contraceptives: a cross-over study.

Thromb Haemost, 84 (2000), pp. 4-8

Medline

[7.]

J. Rosing, G. Tans, G.A. Nicolaes, M.C. Thomanssen, R. Van der Oerle, P.M. Van der Ploeg.

Oral contraceptives and venous trombosis: different sensitivies to activated protein C in women using second-and third generation oral contraceptives.

Br J Haematol, 97 (1997), pp. 233-238

Medline

[8.]

R.N. Prasad, S.C. Koh, O.A. Viegas, S.S. Ratnam.

Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.

Clin Appl Thromb Hemost, 5 (1999), pp. 60-70

Medline

[9.]

S.F. De Bruijn, J. Stam, J.P. Vandenbroucke.

Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group.

Lancet, 351 (1998), pp. 1404

http://dx.doi.org/10.1016/S0140-6736(05)79443-5 | Medline

[10.]

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study.

Lancet, 346 (1995), pp. 1575-1582

Medline

[11.]

World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease.

Lancet, 346 (1995), pp. 1582-1588

Medline

[12.]

Agencia Española del Medicamento.

Comunicación sobre riesgos de medicamentos.

Riesgo de tromboembolismo venoso asociado a la utilización de anticonceptivos orales de tercera generación 2001, Agencia Española del Medicamento, (2001),

[13.]

J.M. Kemmeren, A. Algra, D.E. Grobbee.

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.

Bmj, 323 (2001), pp. 131-134

Medline

[14.]

J.O. Drife.

The third generation pill controversy (continued).

Bmj, 323 (2001), pp. 119-120

Medline

[15.]

R. S´nchez, O. Martinez.